IOVANCE BIOTHERAPEUTICS, INC. (34) | Lease Agreements (7)
Recent Contracts
-
Third Amendment to the Lease Agreement, effective as of November 1, 2021, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC
(Filed With SEC on February 24, 2022)
-
Lease Agreement dated as of February 8, 2021, by and between Iovance Biotherapeutics, Inc. and ARE-San Francisco No. 63, LLC
(Filed With SEC on February 9, 2021)
-
Second Amendment to the Lease Agreement, effective as of June 30, 2020, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC
(Filed With SEC on August 6, 2020)
-
First Amendment to the Office Lease, effective as of June 19, 2019, between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC
(Filed With SEC on November 4, 2019)
-
First Amendment to the Lease Agreement, effective as of August 20, 2019, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC
(Filed With SEC on November 4, 2019)
-
First Amendment to the Lease Agreement dated as of June 19, 2019, by and between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC
(Filed With SEC on June 21, 2019)
-
Lease Agreement dated as of May 28, 2019, by and between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC
(Filed With SEC on June 3, 2019)